Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Stopped Low accrual
Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Anatomic Stage IV Breast Cancer AJCC v8
- Anemia
- Ann Arbor Stage III Hodgkin Lymphoma
- Ann Arbor Stage III Non-Hodgkin Lymphoma
- Ann Arbor Stage IV Hodgkin Lymphoma
- Ann Arbor Stage IV Non-Hodgkin Lymphoma
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Castration-Resistant Prostate Carcinoma
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Hematopoietic and Lymphoid System Neoplasm
- Locally Advanced Pancreatic Adenocarcinoma
- Metastatic Breast Carcinoma
- Metastatic Malignant Solid Neoplasm
- Metastatic Pancreatic Adenocarcinoma
- Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
- Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
- Primary Myelofibrosis
- Recurrent Acute Lymphoblastic Leukemia
- Recurrent Acute Myeloid Leukemia
- Recurrent Chronic Lymphocytic Leukemia
- Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Recurrent Hematologic Malignancy
- Recurrent Hodgkin Lymphoma
- Recurrent Myelodysplastic Syndrome
- Recurrent Myelodysplastic/Myeloproliferative Neoplasm
- Recurrent Myeloproliferative Neoplasm
- Recurrent Non-Hodgkin Lymphoma
- Recurrent Plasma Cell Myeloma
- Recurrent Small Lymphocytic Lymphoma
- Refractory Acute Lymphoblastic Leukemia
- Refractory Acute Myeloid Leukemia
- Refractory Chronic Lymphocytic Leukemia
- Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Refractory Chronic Myelomonocytic Leukemia
- Refractory Hematologic Malignancy
- Refractory Hodgkin Lymphoma
- Refractory Malignant Solid Neoplasm
- Refractory Myelodysplastic Syndrome
- Refractory Myelodysplastic/Myeloproliferative Neoplasm
- Refractory Non-Hodgkin Lymphoma
- Refractory Plasma Cell Myeloma
- Refractory Primary Myelofibrosis
- Refractory Small Lymphocytic Lymphoma
- Stage II Pancreatic Cancer AJCC v8
- Stage III Pancreatic Cancer AJCC v8
- Stage IV Pancreatic Cancer AJCC v8
- Stage IV Prostate Cancer AJCC v8
- Unresectable Pancreatic Adenocarcinoma
Interventions
- DRUG: Abemaciclib
- DRUG: Abiraterone
- DRUG: Afatinib
- BIOLOGICAL: Bevacizumab
- DRUG: Bicalutamide
- PROCEDURE: Biospecimen Collection
- DRUG: Bortezomib
- DRUG: Cabazitaxel
- DRUG: Cabozantinib
- DRUG: Capecitabine
- DRUG: Carboplatin
- DRUG: Celecoxib
- DRUG: Cobimetinib
- DRUG: Copanlisib
- DRUG: Dabrafenib
- DRUG: Dacomitinib
- DRUG: Darolutamide
- DRUG: Dasatinib
- DRUG: Doxorubicin
- BIOLOGICAL: Durvalumab
Sponsor
OHSU Knight Cancer Institute
Collaborators